BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:New Clinical Investigation Exclusivity (3-Year Exclusivity) 
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-04291-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260505
SUMMARY:FDA comments close: New Clinical Investigation Exclusivity (3-Year
  Exclusivity) for Drug Products: Questions and Answers\; Draft Guidance f
 or Industry\; Availability\; Agency Information Collection Activities\; P
 roposed Collection\; Comment Request
DESCRIPTION:Notice. Federal Register 2026-04291. Docket FDA-2024-D-4388. D
 etails: https://docket-clock.pages.dev/doc/2026-04291/ Official: https://
 www.federalregister.gov/documents/2026/03/04/2026-04291/new-clinical-inve
 stigation-exclusivity-3-year-exclusivity-for-drug-products-questions-and-
 answers
URL:https://www.federalregister.gov/documents/2026/03/04/2026-04291/new-cl
 inical-investigation-exclusivity-3-year-exclusivity-for-drug-products-que
 stions-and-answers
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR